Salvage HLA-haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide for graft failure in non-malignant disorders.

MLA

Albert, Michael H., et al. “Salvage HLA-Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Graft Failure in Non-Malignant Disorders.” Bone Marrow Transplantation, vol. 56, no. 9, Sept. 2021, pp. 2248–58. EBSCOhost, https://doi.org/10.1038/s41409-021-01323-9.

APA

Albert, M. H., Sirin, M., Hoenig, M., Hauck, F., Schuetz, C., Bhattacharyya, R., Stepensky, P., Jacoby, E., Güngör, T., Beier, R., & Schulz, A. (2021). Salvage HLA-haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide for graft failure in non-malignant disorders. Bone Marrow Transplantation, 56(9), 2248–2258. https://doi.org/10.1038/s41409-021-01323-9

Chicago

Albert, Michael H, Mehtap Sirin, Manfred Hoenig, Fabian Hauck, Catharina Schuetz, Rajat Bhattacharyya, Polina Stepensky, et al. 2021. “Salvage HLA-Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Graft Failure in Non-Malignant Disorders.” Bone Marrow Transplantation 56 (9): 2248–58. doi:10.1038/s41409-021-01323-9.